(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANÁLOGOS DE CICLOBUTIL NUCLEOSÍDEOS COMO ANTIVIRAIS

ArquivadaInvention PatentPCT · IB2019060430

Application data

Number

112021010236

Type

Invention Patent

Filing

12/04/2019

Publication

08/24/2021

PCT

IB2019060430

Progress at the INPI

  1. Filing12/04/19
  2. Publication08/24/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/04/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/30/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

JANSSEN BIOPHARMA, INC.

US

Inventors

G. W. (pessoa física)

US

M. Z. (pessoa física)

US

Technical data

Priority claims

US

62/778,820 · 12/12/2018

Abstract

ANÁLOGOS DE CICLOBUTIL NUCLEOSÍDEOS COMO ANTIVIRAIS. A presente invenção refere-se aos análogos de ciclobutil nucleosídeo da Fórmula (I), composições farmacêuticas que incluem um ou mais análogos de ciclobutil nucleosídeo e métodos de uso dos mesmos para tratar HBV, HDV e/ou HIV.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/30/2023

RPI 2734

Arquivamento - Art. 33 da LPI

#11.1

03/14/2023

RPI 2723

Notificação de entrada na fase nacional - PCT

#1.3

08/24/2021

RPI 2642

Alteração de dados cadastrais

#1.1

06/08/2021

RPI 2631

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.